Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 24031-24032 [2011-10386]

Download as PDF Federal Register / Vol. 76, No. 83 / Friday, April 29, 2011 / Notices Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–10385 Filed 4–28–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR) srobinson on DSKHWCL6B1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–4:45 p.m., May 18, 2011. 8:30 a.m.–3:15 p.m., May 19, 2011. Place: CDC, 4770 Buford Highway, Atlanta, Georgia 30341. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC and Administrator, NCEH/ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and well being; and (3) train state and local personnel in health work. The BSC, NCEH/ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC and Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agency’s mission to protect and promote people’s health. The board provides advice and guidance that will assist NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and dissemination of results. The board also provides guidance to help NCEH/ ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. VerDate Mar<15>2010 17:39 Apr 28, 2011 Jkt 223001 Matters To Be Discussed: The agenda items for the BSC Meeting on May 18–19, 2011 will include NCEH/ATSDR Office of the Director updates; Program Response to BSC Program Peer Review of the Division of Environmental Hazards and Health Effects; presentation on NCEH/ATSDR Internal Clearance and External Peer Review Policies and Procedures on Scientific Documents; presentation on Public Health Priority Level [GAO Table 2]; an update on The National Conversation; an overview of CDC’s public health activities related to imported drywall; a review of literature for Toxicological Profiles; a presentation on experimental approaches to risk assessment, and an update on CDC’s Response to earthquake, tsunami and radiation release in Japan. Agenda items are subject to change as priorities dictate. Supplementary Information: The public comment period is scheduled on Wednesday, May 18, 2011 from 4:15 p.m. until 4:30 p.m., and Thursday, May 19, 2011 from 2:15 p.m. until 2:30 p.m. Contact Person for More Information: Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, 4770 Buford Highway, Mail Stop F–61, Chamblee, Georgia 30345; telephone 770/488–0575, Fax: 770/ 488–3377; E-mail: smalcom@cdc.gov. The deadline for notification of attendance is May 9, 2011. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2011–10393 Filed 4–28–11; 8:45 am] BILLING CODE 4163–18–P 24031 Obstetrician-Gynecologist Setting, FOA IP11–009, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., June 13, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools, FOA IP11–006; Strategies to Increase Health Care providers Use of Population-Based Immunization Information Systems, FOA IP11–008; Effectiveness in an Intervention to Promote a Targeted Vaccination Program in the Obstetrician-Gynecologist Setting; FOA IP11–009, initial review.’’ Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E00, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–10390 Filed 4–28–11; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Centers for Disease Control and Prevention The meeting announced below concerns Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools, Funding Opportunity Announcement (FOA) IP11–006; Strategies to Increase Health Care Providers Use of Population-Based Immunization Information Systems, FOA IP11–008; and Effectiveness in an Intervention to Promote a Targeted Vaccination program in the PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Time and Date: 8 a.m.–4:30 p.m., May 18, 2011. Place: CDC, Global Communications Center, 1600 Clifton Road, NE., Building 19, Auditorium B, Atlanta, Georgia 30333. E:\FR\FM\29APN1.SGM 29APN1 24032 Federal Register / Vol. 76, No. 83 / Friday, April 29, 2011 / Notices Status: Open to the public, limited only by the space available. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters To Be Discussed: In addition to program updates, the meeting will include a focused discussion on ‘‘Transitioning Infectious Disease Prevention Programs in an Era of Change.’’ Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road, NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639–4461. The Director, Management and Analysis Services Office, has been delegated the authority to sign the Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–10386 Filed 4–28–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10371 and CMS– 10370] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Service, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed srobinson on DSKHWCL6B1PROD with NOTICES AGENCY: VerDate Mar<15>2010 17:39 Apr 28, 2011 Jkt 223001 information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Cooperative Agreement to Support Establishment of State-Operated Health Insurance Exchanges; Use: All States (including the 50 States, consortia of States, and the District of Columbia herein referred to as States) that received a State Planning and Establishment Grant for Affordable Care Act’s Exchanges are eligible for the Cooperative Agreement to Support Establishment of State Operated Insurance Exchanges. Section 1311(b) of the Affordable Care Act provides the opportunity for each State to establish an Exchange no later than January 1, 2014. The State of Alaska did not apply for a Planning grant. Because Alaska did not receive funding under Section 1311 for planning and establishment of an Exchange within one year of the enactment of the Affordable Care Act, by Statute, the state will not be eligible for Section 1311 Exchange planning and establishment money in the future. Section 1311 of the Affordable Care Act provides for grants to States for the planning and establishment of these Exchanges. Given the innovative nature of Exchanges and the statutorily-prescribed relationship between the Secretary and States in their development and operation, it is critical that the Secretary work closely with States to provide necessary guidance and technical assistance to ensure that States can meet the prescribed timelines, federal requirements, and goals of the statute. In order to provide appropriate and timely guidance and technical assistance, the Secretary must have access to timely, periodic information regarding State progress. Consequently, the information collection associated with these grants is essential to facilitating reasonable and appropriate federal monitoring of funds, providing statutorily-mandated assistance to States to implement Exchanges in accordance with Federal requirements, and to ensure that States have all necessary information required to proceed, such that retrospective corrective action can be minimized. There are two levels of awards for States to apply for the Establishment PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 grants. Each level is based on grantee readiness. Level One Establishment grants are open to States that received federal funding for Exchange Planning activities and awardees of the Cooperative Agreements to Support Innovative Exchange Information Technology Systems. Level One Establishment cooperative agreements provide one year of funding to States that are ready to initiate establishment activities having made progress under their Exchange Planning grant. Level Two Establishment cooperative agreements are open to States that received federal funding for Exchange Planning activities and awardees of the Cooperative Agreements to Support Innovative Exchange Information Technology Systems. Level Two Establishment grants are designed to provide funding to applicants who have made significant progress in meeting specific benchmarks in the Exchange establishment process. Level One Establishment grantees may apply for additional funding under Level Two Establishment grants once they have achieved the benchmarks identified in the Level Two Establishment review criteria. There will be four opportunities for Level One Establishment applicants to apply for funding and there will be six opportunities for Level Two Establishment applicants to apply for funding. HHS anticipates Level One Establishment applications will be due: March 30, 2011; June 30, 2011; September 30, 2011; and December 30, 2011 with anticipated Notices of Grant Award made May 16, 2011; August 15, 2011; November 15, 2011; February 16, 2012. HHS anticipates Level Two Establishment applications will be due: March 30, 2011; June 30, 2011; September 30, 2011; December 30, 2011; March 30, 2012, June 29, 2012 with expected Notices of Grant Award made May 16, 2011; August 15, 2011; November 15, 2011; February 15, 2012; May 15, 2012, August 13, 2012. The Period of Performance for Level One Establishment grants is one year after date of award. The Period of Performance for Level Two Establishment grants is through December 31, 2014. HHS anticipates that the Funding Opportunity Announcement will be released on January 20, 2011. Form Number: CMS– 10371 (OCN: 0938–1119); Frequency: Occasionally; Affected Public: State, Local or Tribal Governments; Number of Respondents: 50; Number of Responses: 94; Total Annual Hours: 564 hours. (For policy questions regarding this collection contact Leslie Shah at 301– E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 76, Number 83 (Friday, April 29, 2011)]
[Notices]
[Pages 24031-24032]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10386]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Time and Date: 8 a.m.-4:30 p.m., May 18, 2011.
    Place: CDC, Global Communications Center, 1600 Clifton Road, 
NE., Building 19, Auditorium B, Atlanta, Georgia 30333.

[[Page 24032]]

    Status: Open to the public, limited only by the space available.
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, 
CDC; the Director, OID; and the Directors of the National Center for 
Immunization and Respiratory Diseases, the National Center for 
Emerging and Zoonotic Infectious Diseases, and the National Center 
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the 
following areas: Strategies, goals, and priorities for programs; 
research within the national centers; and overall strategic 
direction and focus of OID and the national centers.
    Matters To Be Discussed: In addition to program updates, the 
meeting will include a focused discussion on ``Transitioning 
Infectious Disease Prevention Programs in an Era of Change.''
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Robin Moseley, M.A.T., 
Designated Federal Officer, OID, CDC, 1600 Clifton Road, NE., 
Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
    The Director, Management and Analysis Services Office, has been 
delegated the authority to sign the Federal Register notices 
pertaining to announcements of meetings and other committee 
management activities for both the Centers for Disease Control and 
Prevention, and the Agency for Toxic Substances and Disease 
Registry.

    Dated: April 21, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-10386 Filed 4-28-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.